Your browser doesn't support javascript.
loading
Bioequivalence and Pharmacokinetics Study of Two Zidovudine/Lamivudine Tablets in Chinese Healthy Volunteers.
Huang, Xiaomei; Wang, Gongzhu; Huang, Jian; Liang, Wu; Guan, Huiyu; Liu, Haisha; Deng, Yuan; You, Yu; Zhang, Bikui.
Afiliación
  • Huang X; Department of Phase I Clinical Trial Research Center, XiangYa BoAi Rehabilitation Hospital, Changsha, People's Republic of China.
  • Wang G; Department of Pharmacy, The Second XiangYa Hospital of Central South University, Changsha, People's Republic of China.
  • Huang J; Changsha Ruiyi Medical Technology Co., Ltd., Changsha, People's Republic of China.
  • Liang W; Changsha Ruiyi Medical Technology Co., Ltd., Changsha, People's Republic of China.
  • Guan H; Department of Phase I Clinical Trial Research Center, XiangYa BoAi Rehabilitation Hospital, Changsha, People's Republic of China.
  • Liu H; Department of Phase I Clinical Trial Research Center, XiangYa BoAi Rehabilitation Hospital, Changsha, People's Republic of China.
  • Deng Y; Department of Phase I Clinical Trial Research Center, XiangYa BoAi Rehabilitation Hospital, Changsha, People's Republic of China.
  • You Y; EverPro Medical Co., Ltd., Changsha, People's Republic of China.
  • Zhang B; Department of Pharmacy, The Second XiangYa Hospital of Central South University, Changsha, People's Republic of China.
Clin Pharmacol Drug Dev ; 13(1): 14-20, 2024 01.
Article en En | MEDLINE | ID: mdl-37986709
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Zidovudina / Lamivudine Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Zidovudina / Lamivudine Límite: Humans País/Región como asunto: Asia Idioma: En Revista: Clin Pharmacol Drug Dev Año: 2024 Tipo del documento: Article